A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responses.

Abstract excerpt

A number of treatment options are available to multiple sclerosis patients, however this needs to be improved. Herein, we designed and synthesized a number of peptides by mutating principal TCR contact residues based on MBP(83-99) peptide epitope. Immunization of SJL/J mice with MBP(83-99) and mutant [A(91)]MBP(83-99), [E(91)]MBP(83-99), [F(91)]MBP(83-99), [Y(91)]MBP(83-99), and [R(91), A(96)]MBP(83-99) peptides,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Count
• Share to Cell Proliferation